Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Interventional Real-World Cohort Study Evaluating BCL-2 Inhibitor-Based Treatment Regimens for Patients With Chronic Lymphocytic Leukemia (CLL)

NCT07874451 is registered in ClinicalTrials.gov with The First Affiliated Hospital with Nanjing Medical University as lead sponsor.

NCT NCT07874451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07874451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Interventional Real-World Cohort Study Evaluating BCL-2 Inhibitor-Based Treatment Regimens for Patients With Chronic Lymphocytic Leukemia (CLL)
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Overall status
Recruiting
Start date
October 31, 2026
Completion date
October 31, 2030
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cll / sll